Nurix Therapeutics, Inc. · NASDAQ:NRIX

Hansen Gwenn sold 1,452 Nurix Therapeutics, Inc. shares (Form 4)

Traded Sep 1, 2026 · Filed Sep 1, 2026

On Sep 1, 2026, Hansen Gwenn (Chief Scientific Officer) sold 1,452 Nurix Therapeutics, Inc. shares at US$25.47 for US$36,982 under a trading plan, leaving 117,227 shares. Filed Sep 1, 2026 (Form 4).

Sold
1,452 shares
Price
US$25.47
Value
US$36,982
Holding after
117,227 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Scientific Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 1, 2026Common StockOption exercise1,452US$1.86118,679Direct
Sep 1, 2026Common StockSale1,452US$25.47117,227Direct

Source

View original at SEC

Related